Cargando…
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high pathogenicity and infectiousness has become a sudden and lethal pandemic worldwide. Currently, there is no accepted specific drug for COVID-19 treatment. Therefore, it is extremel...
Autores principales: | Jia, Kexin, Li, Yijie, Liu, Tiegang, Gu, Xiaohong, Li, Xiaojiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993661/ https://www.ncbi.nlm.nih.gov/pubmed/37220535 http://dx.doi.org/10.1016/j.chmed.2022.06.014 |
Ejemplares similares
-
Efficacy and Safety of “Three Chinese Patent Medicines and Three TCM Prescriptions” for COVID-19: A Systematic Review and Network Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2022) -
Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities
por: Liu, Jia, et al.
Publicado: (2022) -
Protective effects on myelosuppression mice treated by three different classic Chinese medicine formulae
por: Zhao, An-bin, et al.
Publicado: (2011) -
The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19
por: An, Xuedong, et al.
Publicado: (2021) -
DNA based identification of medicinal materials in Chinese patent medicines
por: Chen, Rong, et al.
Publicado: (2012)